Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > A nanomolecular approach for the isolation of foetal cells

January 27th, 2006

A nanomolecular approach for the isolation of foetal cells

Abstract:
The establishment of non-invasive markers for pre-natal diagnosis has long been a research goal. Current invasive procedures have a significant risk of induced abortion (1-2 per cent) or maternal injury, besides considerable discomfort and psychological distress. Foetal cells can be found in the maternal circulation but, so far, due to their low number and degenerating state they have not been considered a reliable for clinical prenatal diagnosis. The overall objective of the SAFER specific targeted research project under FP6 is to exploit breakthroughs at the confluences of bio-, micro- and nanotechnologies to create a low-cost non-invasive intelligent diagnosis system using a nanotechnology-based device for the isolation, enrichment and detection of foetal cells from maternal blood.

Source:
CORDIS

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Possible Futures

'Spooky action at a distance': Researchers develop module for quantum repeater May 23rd, 2018

Columbia Researchers Squeeze Light into Nanoscale Devices and Circuits: Team is first to directly image propagation and dynamics of graphene plasmons at very low temperatures; findings could impact optical communications and signal processing May 23rd, 2018

NIST Puts the Optical Microscope Under the Microscope to Achieve Atomic Accuracy May 22nd, 2018

Magnesium magnificent for plasmonic applications: Rice University, University of Cambridge synthesize and test nanoparticles of abundant material May 22nd, 2018

Nanomedicine

New blood test rapidly detects signs of pancreatic cancer May 17th, 2018

Elastic microspheres expand understanding of embryonic development and cancer cells May 15th, 2018

Nanomedicine -- Targeting cancer cells with sugars May 14th, 2018

NanoBio Announces Corporate Name Change to BlueWillow Biologics and Closes $10M Series A Financing: Move Reflects Focus on Advancing Several Intranasal Vaccines to Human Studies May 9th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project